Navigating successful eConsent adoption from sponsor to site

eConsent from Sponsor to Site: Navigating successful eConsent adoption in clinical trials

A deep dive on the pivotal role of eConsent in optimizing modern clinical trials. We delve into the nuances and scope of eConsent adoption while drawing from real-life scenarios in the pharmaceutical and medical device industries.

Meet your expert panelists:
Derk Arts, CEO and Founder of Castor, MD, PhD with over fifteen years of experience in medicine, research and technology. Derk founded Castor to solve the biggest issues in clinical research including how to enhance patient satisfaction through eConsent.

Leanne Walsh, With 20 years of experience at firms including Servier Laboratories, Medtronic, and Johnson & Johnson, Leanne established Northern Light Lifescience to offer consultancy services to leading medtech organizations.

Discussion Highlights:

Challenges of eConsent Adoption: How to navigate barriers of eConsent adoption from both the site and sponsor perspectives.
Technology Capabilities: A focus on eConsent capabilities that streamline workflows and foster improved collaborations between all stakeholders.
Regulation & IRB Submission: Invaluable insights into the challenging process of managing regulation and IRB submissions, facilitated through real-life case studies.
Future Perspectives: Envisioning the future of clinical trials with stronger eConsent adoption, better technology and the use of AI.